Eli Lilly Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,058

-1.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (123)	4/7/1998 8:22:00 AM
From: lazarre	Read Replies (1) of 642

Anthony: Re: CNN Actually, it was Dr. Steven Goldstein who was introduced at the start of the show as being connected with Lilly. The woman was from the National Cancer Institute and the other guy was a doc/academic. My take on it was this: tamoxifen ( on the one hand ) was truly a watershed for women who had and feared breast cancer. On the other hand there were enough potential side effects ( particularly the chance to incur uterine cancer ) that you really had to think twice about embarking on a treatment program. Ok. Heres where it really got good: Goldstein was asked at the end of the show if he would recommend to his wife or mom-in-law- tamoxifen. I paraphrase from memeory here: maybe, but why not prescribe ( of course when available ) the new generation of serms that not only was an estrogen blocker for the breast but the uterus as well. Here it was mentioned for the second time during the program: raloxifene. Which of course is Evista ; I don't think Dr. Goldstein or any other doc could mention Evista by name ( anyone out there care to enlighten us about that?? ). All agreed that raloxifene was a ways off but I sense not that far away; what with the news going to snowball into critical mass regarding tamoxifen and the associated news about a similar drug without, perhaps, the harmful side effects. Note how an active lobby succeeded in pushing for aggressive FDA approval of drugs to treat HIV. Here you have a more socially acceptable vested interest group ( 135 million women ) going to do the same thing. I think that when Lilly went exploring for gold with Evista they had no idea it was going to turn into a diamond. Just my opinion. Lazarre

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next